ReviewCurrent pharmaceutical design2017
Protein Kinase Inhibitors as Therapeutic Drugs in AML: Advances and Challenges.
Yuan Ling et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewCurrent pharmaceutical design2017
Yuan Ling et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.